Insider Trading History of Stamler David A

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Stamler David A since 2009. The trader's CIK number is 1440127. At the time of the last reporting, Stamler David A was the SVP, Chief Medical O of Auspex Pharmaceuticals, Inc.. (stock ticker symbol ASPX). Also see all insider trading activities at Auspex Pharmaceuticals, Inc..

Note that in the past Stamler David A also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Auspex Pharmaceuticals, Inc. (ASPX) by Stamler David A

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2015 ASPX 0 $0 3,000 $239,436 3,000 $2,700
2014 ASPX 0 $0 2,660 $142,583 2,660 $2,394

Yearly summary of insider trading at Xenoport Inc (XNPT) by Stamler David A

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2010 XNPT 0 $0 0 $0 3,500 $0
2009 XNPT 0 $0 0 $0 5,809 $0


Insider trading activities at 2 companies by Stamler David A:

1. Auspex Pharmaceuticals, Inc. (ASPX)

2. Xenoport Inc (XNPT)

Table 1. Insider trading of Auspex Pharmaceuticals, Inc. (ASPX) by Stamler David A

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2015-03-16 ASPX Sale 3,000 79.81 239,436
2015-03-16 ASPX Option Ex 3,000 .90 2,700
2014-12-22 ASPX Sale 2,660 53.60 142,583
2014-12-22 ASPX Option Ex 2,660 .90 2,394

Table 2. Insider trading of Xenoport Inc (XNPT) by Stamler David A

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2010-08-02 XNPT Option Ex 2,500 .00 0
2010-01-28 XNPT Option Ex 1,000 .00 0
2009-08-10 XNPT Option Ex 2,500 .00 0
2009-01-14 XNPT Option Ex 3,309 .00 0

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Stamler David A (SVP, Chief Medical O of Auspex Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.